Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | TYMS | P04818 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15521433 | 0.84 | CYP2A6 (0.39) | ALDH1A1TDP1 | |
| SCHEMBL31633891 | 0.84 | CYP2A6 (0.39) | ALDH1A1TDP1 | |
| SCHEMBL13483291 | 0.80 | CYP1A2 (0.31) | TYMS | |
| SCHEMBL10137937 | 0.80 | AXL (0.39) | MEN1ALDH1A1MAPTKMT2ATYMS | |
| SCHEMBL29958469 | 0.72 | CYP1A2 (0.54) | KDM4EMEN1ALDH1A1KMT2ATYMS | |
| SCHEMBL15922535 | 0.72 | CYP1A2 (0.54) | KDM4EMEN1ALDH1A1KMT2ATYMS | |
| SCHEMBL10622604 | 0.72 | DYRK1A (0.35) | KDM4EALDH1A1MAPT | |
| SCHEMBL1005904 | 0.71 | HSP90AA1 (0.33) | BCL2KDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL20356138 | 0.71 | KDM4E (0.34) | KDM4EMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL2679177 | 0.71 | CYP1A2 (0.45) | MEN1ALDH1A1MAPTHPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3816238-A1 | POLYPARAPERYLENE DERIVATIVES AND METHODS FOR MAKING SAME | TEXTILCHEMIE DR. PETRY GMBH (DE) | 2021-05-05 | — | — | EP | disclosed |
| EP-2890668-B1 | PERYLENE DERIVATIVES AS BUILDING BLOCKS FOR ORGANIC ELECTRONIC MATERIALS AND DYESTUFF | BASF SE (DE) | 2019-08-21 | — | — | EP | disclosed |
| US-9382264-B2 | Conveniently prepared naphthalene and perylene derivatives as building blocks for organic electronic materials and dyestuff | BASF SE (DE) | 2016-07-05 | — | — | US | disclosed |
| US-20150225418-A1 | CONVENIENTLY PREPARED NAPHTHALENE AND PERYLENE DERIVATIVES AS BUILDING BLOCKS FOR ORGANIC ELECTRONIC MATERIALS AND DYESTUFF | BASF SE (DE) | 2015-08-13 | — | — | US | disclosed |
| EP-2890668-A2 | CONVENIENTLY PREPARED NAPHTHALENE AND PERYLENE DERIVATIVES AS BUILDING BLOCKS FOR ORGANIC ELECTRONIC MATERIALS AND DYESTUFF | BASF SE (DE) | 2015-07-08 | — | — | EP | disclosed |
| WO-2014033622-A2 | CONVENIENTLY PREPARED NAPHTHALENE AND PERYLENE DERIVATIVES AS BUILDING BLOCKS FOR ORGANIC ELECTRONIC MATERIALS AND DYESTUFF | BASF SE (DE) | 2014-03-06 | — | — | WO | disclosed |
| EP-0965629-B1 | Compound for organic electroluminescence device and organic electroluminescence device | TOYO INK MFG CO (JP) | 2003-01-15 | — | — | EP | disclosed |
| US-6329084-B1 | FLAT PANEL OR DISPLAY, BRIGHTNESS, RED COLOR, TERTRA(DIARYLAMINO) PERYLENES | TOYO INK MFG. CO., LTD. (JP) | 2001-12-11 | — | — | US | disclosed |
| EP-0965629-A1 | Compound for organic electroluminescence device and organic electroluminescence device | TOYO INK MFG. CO., LTD. (JP) | 1999-12-22 | — | — | EP | disclosed |
| EP-0156997-B1 | PROCESS FOR THE CONCENTRATION OF LIGHT IN A PLANE SURFACE | BASF Aktiengesellschaft (DE) | 1988-07-20 | — | — | EP | disclosed |
| US-4618694-A | CONCENTRATING LIGHT IN POLYMETHYL METHACRYLATE; PHOTOSTABLE | BASF AKTIENGESELLSCHAFT (DE) | 1986-10-21 | — | — | US | disclosed |
| EP-0156997-A1 | Process for the concentration of light in a plane surface | BASF Aktiengesellschaft (DE) | 1985-10-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150225418-A1 | CONVENIENTLY PREPARED NAPHTHALENE AND PERYLENE DERIVATIVES AS BUILDING BLOCKS FOR ORGANIC ELECTRONIC MATERIALS AND DYESTUFF | NR0B2, NR0B1, OR10J3 | BCL2 3202/4885KDM4E 3903/4885MEN1 1763/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.